Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06460363 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Transcranial Alternating Current Stimulation on Patients with Delirium and Critical Illness (DeliTACS)

Study acronym: DeliTACS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 1, 2024 to Sep 6, 2024
    • Site details revised
    v4
  2. Study sites: 0 to 1v3
  3. Primary endpoint revisedv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn if transcranial alternating current stimulation can shorten the duration of delirium in intensive care setting. The main question it aims to answer: * Is it possible to shorten the duration of delirium with transcranial alternating current stimulation? Researchers will compare experimental treatment to sham. Participants will receive experimental or sham treatment on maximum of two days depending on their delirium status. Duration of delirium is recorded and reported as "days alive and free of delirium".
Trial Details
NCT Number NCT06460363
Lead Sponsor Kuopio University Hospital
Conditions
(from sponsor)		 Delirium
Related terms Delirium, Spondylocostal Dysostosis 4, Autosomal Dominant
Enrollment 78 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov